| Crystal Crawford, | |
|
2557 Hawks Rd, Ann Arbor, MI 48108-1310 | |
| (734) 945-3054 | |
| Not Available |
| Full Name | Crystal Crawford |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 2557 Hawks Rd, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134524911 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 4703105465 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Crystal Crawford, 2557 Hawks Rd, Ann Arbor, MI 48108-1310 Ph: (734) 945-3054 | Crystal Crawford, 2557 Hawks Rd, Ann Arbor, MI 48108-1310 Ph: (734) 945-3054 |
News Archive
Researchers in Columbia, South America, conducted a retrospective observational study within six hospitals to identify risk factors of maternal mortality in mechanically ventilated pregnant patients.
Ipsen, a global biopharmaceutical group, and Invida Group, the leading healthcare commercialization solutions partner in the Asia Pacific region, announced today an agreement for the exclusive distribution and promotion by Invida of Ipsen's drugs Diphereline® 3.75mg & 11.25mg, Somatuline® Autogel® and Increlex® in selected countries in South-East Asia.
Dental researchers are combining the ease of digital photography with the Internet to develop a new and inexpensive way to screen for a common childhood oral disease.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to extensive generic erosion, the hypertension drug market will be constrained through 2018 by a pipeline containing very few emerging therapies with novel mechanisms of action. Gilead's darusentan was positioned to be the next emerging therapy with a novel mechanism of action to reach the hypertension market. However, following darusentan's failure to meet its primary endpoint in the recent DORADO-AC Phase III clinical trial, further development of the agent has been terminated.
› Verified 7 days ago
Michael Atiefu, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2667 Adrienne Dr, Ann Arbor, MI 48103 Phone: 734-383-2799 | |
Lisa Heard, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2215 Fuller Road, Ann Arbor, MI 48105 Phone: 419-259-2000 | |
Linmyers Jean Myers, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2850 S Industrial Hwy Ste 75, Ann Arbor, MI 48104 Phone: 734-677-1515 | |
Stephanie Biccum, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2215 Fuller Rd, Ann Arbor, MI 48105 Phone: 517-764-3609 | |
Jacqueline Maxey, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2850 S Indurstrial Hwy, Suite 75, Ann Arbor, MI 48104 Phone: 734-477-7204 | |
Katrina Louise Person, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2215 Fuller Rd, Ann Arbor, MI 48105 Phone: 734-222-4212 Fax: 734-845-5301 |